177 related articles for article (PubMed ID: 25044030)
21. Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study.
Zhu B; Edson-Heredia E; Gatz JL; Guo J; Shuler CL
Clin Ther; 2013 Sep; 35(9):1376-85. PubMed ID: 23954091
[TBL] [Abstract][Full Text] [Related]
22. Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment.
Sparks JA; Lesperance T; Accortt NA; Solomon DH
Arthritis Care Res (Hoboken); 2019 Apr; 71(4):512-520. PubMed ID: 29799667
[TBL] [Abstract][Full Text] [Related]
23. Psoriatic arthritis treatment regimens, therapy duration and reasons for cessation in the biologics era: a multi-centre Australian study.
Tymms K; Kelly A; Bird P; Griffiths H; de Jager J; Littlejohn G; Louw S; Roberts L; Youssef P; Zochling J; Nichols D
Int J Rheum Dis; 2018 Feb; 21(2):510-516. PubMed ID: 28730757
[TBL] [Abstract][Full Text] [Related]
24. Determining the predictive value of Read codes to identify congenital cardiac malformations in the UK Clinical Practice Research Datalink.
Hammad TA; Margulis AV; Ding Y; Strazzeri MM; Epperly H
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1233-8. PubMed ID: 24002995
[TBL] [Abstract][Full Text] [Related]
25. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway.
Kerola AM; Sexton J; Wibetoe G; Rollefstad S; Crowson CS; Mars N; Kazemi A; Haavardsholm EA; Kvien TK; Semb AG
Semin Arthritis Rheum; 2021 Oct; 51(5):1081-1088. PubMed ID: 34450506
[TBL] [Abstract][Full Text] [Related]
26. Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance.
Walsh JA; Pei S; Burningham Z; Penmetsa G; Cannon GW; Clegg DO; Sauer BC
J Rheumatol; 2018 Mar; 45(3):430-436. PubMed ID: 29142040
[TBL] [Abstract][Full Text] [Related]
27. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
[TBL] [Abstract][Full Text] [Related]
28. Accuracy of pneumonia hospital admissions in a primary care electronic medical record database.
Meropol SB; Metlay JP
Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):659-65. PubMed ID: 22374684
[TBL] [Abstract][Full Text] [Related]
29. Validation of claims-based algorithms for psoriatic arthritis.
Lee H; Ford JA; Jin Y; Cho SK; Santiago Ortiz AJ; Tong AY; Kim SC
Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):404-408. PubMed ID: 31849154
[TBL] [Abstract][Full Text] [Related]
30. Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.
Queiro R; Cañete JD; Montilla C; Abad MA; Montoro M; Gómez S; Cábez A;
J Rheumatol; 2019 Jul; 46(7):710-715. PubMed ID: 30709957
[TBL] [Abstract][Full Text] [Related]
31. Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients.
Simon D; Kleyer A; Bayat S; Tascilar K; Kampylafka E; Meinderink T; Schuster L; Petrov R; Liphardt AM; Rech J; Schett G; Hueber AJ
Arthritis Res Ther; 2019 Jul; 21(1):162. PubMed ID: 31269973
[TBL] [Abstract][Full Text] [Related]
32. Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database.
Lo Re V; Haynes K; Goldberg D; Forde KA; Carbonari DM; Leidl KB; Hennessy S; Reddy KR; Pawloski PA; Daniel GW; Cheetham TC; Iyer A; Coughlin KO; Toh S; Boudreau DM; Selvam N; Cooper WO; Selvan MS; VanWormer JJ; Avigan MI; Houstoun M; Zornberg GL; Racoosin JA; Shoaibi A
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):861-72. PubMed ID: 23801638
[TBL] [Abstract][Full Text] [Related]
33. Validation of psoriatic arthritis diagnoses in electronic medical records using natural language processing.
Love TJ; Cai T; Karlson EW
Semin Arthritis Rheum; 2011 Apr; 40(5):413-20. PubMed ID: 20701955
[TBL] [Abstract][Full Text] [Related]
34. The accuracy of administrative health data for identifying patients with rheumatoid arthritis: a retrospective validation study using medical records in Western Australia.
Almutairi K; Inderjeeth C; Preen DB; Keen H; Rogers K; Nossent J
Rheumatol Int; 2021 Apr; 41(4):741-750. PubMed ID: 33620516
[TBL] [Abstract][Full Text] [Related]
35. Validation of rheumatoid arthritis diagnoses in health care utilization data.
Kim SY; Servi A; Polinski JM; Mogun H; Weinblatt ME; Katz JN; Solomon DH
Arthritis Res Ther; 2011 Feb; 13(1):R32. PubMed ID: 21345216
[TBL] [Abstract][Full Text] [Related]
36. What evidence is there for a delay in diagnostic coding of RA in UK general practice records? An observational study of free text.
Ford E; Carroll J; Smith H; Davies K; Koeling R; Petersen I; Rait G; Cassell J
BMJ Open; 2016 Jun; 6(6):e010393. PubMed ID: 27354069
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases.
Singh JA; Holmgren AR; Krug H; Noorbaloochi S
Arthritis Rheum; 2007 May; 57(4):648-55. PubMed ID: 17471541
[TBL] [Abstract][Full Text] [Related]
38. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology and Medication Pattern Change of Psoriatic Diseases in Taiwan from 2000 to 2013: A Nationwide, Population-based Cohort Study.
Wei JC; Shi LH; Huang JY; Wu XF; Wu R; Chiou JY
J Rheumatol; 2018 Mar; 45(3):385-392. PubMed ID: 29335350
[TBL] [Abstract][Full Text] [Related]
40. High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission.
Araujo EG; Finzel S; Englbrecht M; Schreiber DA; Faustini F; Hueber A; Nas K; Rech J; Schett G
Ann Rheum Dis; 2015 Apr; 74(4):655-60. PubMed ID: 24336010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
